stars 1 stars 2 stars 3

Solsten develops AptaSystem®, a widely applicable platform for fast and simple detection of analytes including diagnostic targets. AptaSystem® comprises an inexpensive, disposable biosensor, AptaChip® and an easy to operate instrument, AptaViewer® for reading the analytical result. When a sample is applied to the AptaChip®, presence of the analyte of interest will be electrochemically detected by a corresponding specific aptamer, and the read-out reported within a few minutes. The AptaSystem® technology is not limited to diagnostic use in humans and animals, but is also applicable for analysis of drug metabolites, food and feed safety, and environmental factors. Solsten offers its AptaSystem® to strategic partners and prospective investors – and thereby provides a new technology and business opportunity superiorly positioned for the fast growing point-of-care testing (POCT) market.

Solsten Diagnostics International ApS Questions

The Solsten Diagnostics International ApS annual revenue was $1 million in 2026.

Niels Foged is the CEO of Solsten Diagnostics International ApS.

2 people are employed at Solsten Diagnostics International ApS.

The NAICS codes for Solsten Diagnostics International ApS are [541, 33, 54, 331].

The SIC codes for Solsten Diagnostics International ApS are [20, 21, 87, 873].

Top Solsten Diagnostics International ApS Employees

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users